Cite
Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.
MLA
Rahman, Rifaquat, et al. “Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.” International Journal of Radiation Oncology, Biology, Physics, vol. 108, no. 3, Nov. 2020, pp. 716–24. EBSCOhost, https://doi.org/10.1016/j.ijrobp.2020.05.010.
APA
Rahman, R., Trippa, L., Alden, S., Fell, G., Abbasi, T., Mundkur, Y., Singh, N. K., Talawdekar, A., Husain, Z., Vali, S., Ligon, K. L., Wen, P. Y., & Alexander, B. M. (2020). Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide. International Journal of Radiation Oncology, Biology, Physics, 108(3), 716–724. https://doi.org/10.1016/j.ijrobp.2020.05.010
Chicago
Rahman, Rifaquat, Lorenzo Trippa, Stephanie Alden, Geoffrey Fell, Taher Abbasi, Yatin Mundkur, Neeraj K. Singh, et al. 2020. “Prediction of Outcomes with a Computational Biology Model in Newly Diagnosed Glioblastoma Patients Treated with Radiation Therapy and Temozolomide.” International Journal of Radiation Oncology, Biology, Physics 108 (3): 716–24. doi:10.1016/j.ijrobp.2020.05.010.